To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06625775
Title Dose Escalation and Expansion of BBO-10203 in Advanced Solid Tumors (BREAKER-101)
Acronym BREAKER-101
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors TheRas, Inc., d/b/a BridgeBio Oncology Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
University of California Los Angeles RECRUITING Los Angeles California 90095 United States Details
Indiana University Simon Comprehensive Cancer Center RECRUITING Indianapolis Indiana 46202 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
Mary Crowley Cancer Research RECRUITING Dallas Texas 75230 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Peter MacCallum Cancer Centre RECRUITING Melbourne Victoria 3000 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field